Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016
Summary
GlobalData's clinical trial report, “Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016" provides an overview of Von Willebrand Disease (Factor VIII Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Von Willebrand Disease (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Von Willebrand Disease (Factor VIII Deficiency) 32
Jul 19, 2016: Shire presents Update On Vonvendi at International congress of the World Federation of Hemophilia 32
Clinical Trial Profile Snapshots 33
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68
List Of Tables
List of Tables
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 16
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 20
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2016* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
List Of Figures
List of Figures
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 15
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 19
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 66
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Von Willebrand Disease (Factor VIII Deficiency) 32
Jul 19, 2016: Shire presents Update On Vonvendi at International congress of the World Federation of Hemophilia 32
Clinical Trial Profile Snapshots 33
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68
List Of Tables
List of Tables
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 16
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 20
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2016* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
List Of Figures
List of Figures
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 15
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Von Willebrand Disease (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 19
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Von Willebrand Disease (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 66
